Toxic epidermal necrolysis: Difference between revisions

Line 6: Line 6:


==Clinical Features==
==Clinical Features==
[[File:Necrolysis epidermalis toxica 02.jpg|thumb]]|Toxic epidermal necrolysis on legs]]
[[File:Necrolysis epidermalis toxica 02.jpg|thumb|Toxic epidermal necrolysis on legs]]
*Malaise, anorexia, [[myalgia]]s, [[arthralgia]]s, [[fever]], painful skin, GI symptoms
*Malaise, anorexia, [[myalgia]]s, [[arthralgia]]s, [[fever]], painful skin, GI symptoms
*Extracutaneous manifestations may persist for 1-2 weeks following skin symptoms
*Extracutaneous manifestations may persist for 1-2 weeks following skin symptoms

Revision as of 13:23, 16 November 2019

Background

  • Explosive dermatosis with tender erythema, bullae, and subsequent exfolliation
  • Most commonly caused by medications

Clinical Features

Toxic epidermal necrolysis on legs
  • Malaise, anorexia, myalgias, arthralgias, fever, painful skin, GI symptoms
  • Extracutaneous manifestations may persist for 1-2 weeks following skin symptoms
  • Exam with warm tender erythema with overlying flaccid bullae, erosions with exfoliation
  • Positive Nikolsky's sign (able to rub off superficial layers of skin with pressure)
  • Mucosal involvement (oral, conjunctival, respiratory, GU)
  • Systemic toxicity
  • 25-35% Mortality
  • Predictors of poor prognosis include: age, extent of disease, leukopenia, azotemia, and thrombocytopenia

Differential Diagnosis

Erythematous rash

Evaluation

  • History of drug exposure
  • Prodrome of malaise and fever
  • Positive Nikolsky sign
  • Oral, ocular, and/or genital mucositis with painful erosions
  • Necrosis and sloughing of the epidermis
  • Diagnosis is made my skin biopsy
  • SJS vs TEN
    • SJS - skin detachment of <10% of BSA
    • TEN – skin detachment of >30% of BSA

Management

Disposition

  • ICU
  • Best cared for in a burn unit
  • Immediate derm consult

References

<UpToDate>